PatenSee Achieves FDA Breakthrough Designation for Revolutionary Hemodialysis Monitoring Technology PatenSee has been granted FDA's Breakthrough Device Designation for its non-contact vascular access management technology, promising enhanced kidney care.

PatenSee Achieves FDA Breakthrough Designation for Revolutionary Hemodialysis Monitoring Technology #United_States #Detroit #FDA_Breakthrough #PatenSee #Hemodialysis